Techno Medica (6678) · RiskMitigated
Risk of Delays in Product Supply Due to Semiconductor Shortages
First written in FY2022-Q3. 1 of 2 entries say "Mitigated", first in FY2023. Latest entry: FY2023.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Product Supply Delays Due to Semiconductor ShortageA theme 12 companies write about · 12 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2024: 1 of 7 companies on the "Worse" side.
3 other companies' latest entry also says "Mitigated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2023MitigatedAnnual report
「During the fiscal year, production results fluctuated significantly, mainly because inventories were increased in preparation for the risk of shortages, including semiconductor shortages, affecting blood collection tube preparation equipment and systems.」
The company increased inventory to prepare for the risk of stockouts caused by the semiconductor shortage. This does not state that supply delays caused by the semiconductor shortage affected business performance. - FY2022-Q3First statedAnnual report
「Although concerns arose during the period that the semiconductor shortage could delay the supply of products to customers, this did not have an impact on business performance.」
The Company explicitly identified for the first time concerns that the semiconductor shortage could delay product supplies to customers during the period. However, because this did not affect business performance, it was distinguished from the materialization of the risk.